Landanger group partners with 21 invest

«From the beginning to the end, the relationships were direct, professional and transparent. We have obtained a very competitive financing and I doubt another investment bank would have done a better job»

Benoît Landanger, Chairman of Landanger Group

The Landanger Group is an emblematic French family business of the Medtech sector whose history began in 1947. At the time, Landanger was the European leader in orthopedic before being acquired by Johnson & Johnson for its innovative Corail Hip implant, which remains the most implanted in the world. During the transaction, the surgical instrument activity was retained by the family.

Under the management of Benoît Landanger, the founders’ grandson, the company became again a leader in surgical instrumentation. The group has created two strong brands, Landanger and Delacroix-Chevalier, with a broad product portfolio dedicated to general surgery and specialties such as cardio-thoracic, neurosurgery, endoscopy or more recently ENT, etc., including minimally invasive, reusable or disposable instruments.

May 2019 – After numerous discussions, the shareholders decided to partner with 21 Invest, a private equity firm to accelerate the growth both organically and through acquisitions in France and abroad, especially in the United States.